{
  "meta": {
    "title": "102_Covid_19_-_Investigations",
    "url": "https://brainandscalpel.vercel.app/102-covid-19-investigations-0db07cf7.html",
    "scrapedAt": "2025-11-30T12:28:22.482Z"
  },
  "questions": [
    {
      "text": "During the swab collection for COVID-19 testing, the healthcare professional asks you to tilt your head approximately to what degree?",
      "choices": [
        {
          "id": 1,
          "text": "30 degrees"
        },
        {
          "id": 2,
          "text": "45 degrees"
        },
        {
          "id": 3,
          "text": "70 degrees"
        },
        {
          "id": 4,
          "text": "15 degrees"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>For collecting nasal/nasopharyngeal/oropharyngeal specimens for <strong>COVID-19 testing</strong>, a person&rsquo;s head should be tilted back<strong> 70 degrees.&nbsp;</strong></p>\n<p><strong>Guidelines for specimen collection:</strong></p>\n<ul>\n<li>Use appropriate PPE and maintain proper infection control measures</li>\n<li>Restricted entry to visitors or attendants during sample collection</li>\n<li>Complete the requisition form for each specimen submitted</li>\n<li>Proper disposal of all waste generated</li>\n</ul>\n<p>Recommended <strong>personal protective equipment</strong> (PPE) for the healthcare professional who is collecting the specimen or coming within 6 feet of the patient:&nbsp;</p>\n<ul>\n<li>N95 or higher-level respirator (or facemask if a respirator is not available)</li>\n<li>eye protection</li>\n<li>gloves</li>\n<li>gown</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6838",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is a false statement regarding sample collection for COVID-19 testing?",
      "choices": [
        {
          "id": 1,
          "text": "The nasal swab is placed in a different viral transport media tube as the throat swab."
        },
        {
          "id": 2,
          "text": "Oropharyngeal sample is not collected using a calcium alginate swab."
        },
        {
          "id": 3,
          "text": "Swab is rubbed over the tonsillar pillars and posterior oropharynx for oropharyngeal swab."
        },
        {
          "id": 4,
          "text": "Swab is inserted parallel to the palate for nasopharyngeal swab."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The nasal swab is placed in the<strong> same viral transport media tube</strong> as the throat swab.</p>\n<p>Samples that can be used for COVID-19 testing are:</p>\n<ul>\n<li>Throat and nasal swab</li>\n<li>Oropharyngeal swab</li>\n<li>Nasopharyngeal swab&nbsp;</li>\n<li>Broncho-alveolar lavage&nbsp;</li>\n<li>Endotracheal aspirate&nbsp;</li>\n</ul>\n<p><strong>Combined throat and nasal swabs:</strong></p>\n<ul>\n<li>Tilt patient's head back 70 degrees.</li>\n<li>Gently rotate the swab and insert less than one inch into the nostril. Rotate the swab several times against the nasal wall and repeat the same in the other nostril with the same swab.</li>\n<li>Place the tip of the swab into the transport media tube and cut off the applicator.</li>\n<li>For throat swab, take a second swab, insert into the mouth and swab the posterior pharynx and tonsillar areas.</li>\n<li><strong>Place the tip of the swab</strong> into the <strong>same tube</strong> and cut off the applicator tip.</li>\n</ul>\n<p><strong>Oropharyngeal swab:</strong></p>\n<ul>\n<li>Tilt patient's head back 70 degrees.</li>\n<li><strong>Rub swab </strong>over <strong>both tonsillar pillars </strong>and<strong> posterior oropharynx </strong>and avoid touching the tongue, teeth, and gums.</li>\n<li>Use only synthetic fiber swabs with plastic shafts. <strong>Avoid calcium alginate swabs </strong>and<strong> swabs with wooden shafts.</strong></li>\n<li>Place the swab immediately into sterile tubes with viral transport medium.</li>\n</ul>\n<p><strong>Nasopharyngeal swab:&nbsp;</strong></p>\n<ul>\n<li>Tilt the patient's head back 70 degrees</li>\n<li>Insert flexible swab through the nares <strong>parallel to the palate</strong> <strong>(not upwards)</strong> until resistance is encountered&nbsp;</li>\n<li>Rub and roll the swab and leave it in place for several seconds to absorb secretions before removing</li>\n<li>Place the swab immediately into sterile tubes with viral transport medium.</li>\n</ul>\n<p><strong>Viral transport mediums:</strong></p>\n<ul>\n<li aria-level=\"1\">Hanks balanced salt solution with Ca and Mg and heat inactivated fetal bovine serum, gentamicin and amphotericin B (most commonly used)</li>\n<li aria-level=\"1\">Sterile saline</li>\n<li aria-level=\"1\">Phosphate buffered saline-glycerol medium</li>\n<li aria-level=\"1\">Amies medium</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6826",
      "difficulty": "medium"
    },
    {
      "text": "The specimens collected for COVID-19 testing should be transported to the lab at what temperatures?",
      "choices": [
        {
          "id": 1,
          "text": "-30 degree C"
        },
        {
          "id": 2,
          "text": "-4 to -8 degree C"
        },
        {
          "id": 3,
          "text": "2 to 8 degree C"
        },
        {
          "id": 4,
          "text": "12 to 16 degree C"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Specimens collected for COVID-19 testing should be transported to the lab at a temperature of <strong>2 to 8 degrees C</strong> as per the <strong>WHO</strong> guidelines. The <strong>ICMR/NIV</strong> guidelines recommend <strong>4 degrees C</strong> for transport to the laboratory.&nbsp;</p>\n<p>Both guidelines recommend storing specimens at <strong>-70&deg;C or below</strong> if a <strong>delay</strong> in testing or shipping is expected.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Specimen</strong></td>\n<td><strong>Sensitivity</strong></td>\n</tr>\n<tr>\n<td>Bronchoalveolar lavage fluid</td>\n<td>93%</td>\n</tr>\n<tr>\n<td>Sputum</td>\n<td>72%</td>\n</tr>\n<tr>\n<td>Nasopharyngeal swab</td>\n<td>63%</td>\n</tr>\n<tr>\n<td>Oropharyngeal swab</td>\n<td>32%</td>\n</tr>\n<tr>\n<td>Faeces</td>\n<td>29%</td>\n</tr>\n<tr>\n<td>Blood</td>\n<td>1%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6839",
      "difficulty": "easy"
    },
    {
      "text": "Which level of BSL (Biosafety level) facility is required during specimen handling for molecular testing of SARS CoV 2?",
      "choices": [
        {
          "id": 1,
          "text": "BSL 1"
        },
        {
          "id": 2,
          "text": "BSL 2"
        },
        {
          "id": 3,
          "text": "BSL 3"
        },
        {
          "id": 4,
          "text": "BSL 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Specimen handling for <strong>molecular testing of SARS CoV 2</strong> would require <strong>BSL-2</strong> or equivalent facilities.</p>\n<p>Microbiology and pathology laboratories performing diagnostic tests on a stool or respiratory specimen should handle potential SARS-CoV specimens using Biosafety Level 2 (BSL-2).&nbsp;<strong>Virus culture</strong> and initial characterization of viral agents recovered in cultures requires minimum <strong>BSL-3 facilities</strong>.</p>\n<p><strong>Note:</strong> Biosafety levels include a specific combination of work practices, safety equipment, and facilities that are designed to minimize the exposure of workers and the environment to infectious agents. There are four biosafety levels.</p><hr><h3>Related Pearl: Laboratory Biosafety Levels (BSL)</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Biosafety level</strong></td>\n<td><strong>Lab practices</strong></td>\n<td><strong>Safety Equipment</strong></td>\n<td><strong>Facility</strong></td>\n</tr>\n<tr>\n<td><strong>BSL 1</strong></td>\n<td>\n<p>Work on open lab benches or tables.</p>\n<p>Good microbiological techniques followed</p>\n</td>\n<td>PPE (lab coats, gloves, eye protection) are worn as needed.</td>\n<td>\n<p>Sink for hand washing.</p>\n<p>Separate doors from the rest of the facility.</p>\n</td>\n</tr>\n<tr>\n<td><strong>BSL 2</strong></td>\n<td>Access restricted to the laboratory</td>\n<td>\n<p>Appropriate PPE (lab coats, gloves, eye protection, and face shields).</p>\n<p>Biological safety cabinets (BSC) to prevent potential aerosols.</p>\n<p>Autoclave or alternative method for decontamination</p>\n</td>\n<td>\n<p>Sink and eyewash easily available.</p>\n<p>Self-closing doors.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>BSL 3</strong></td>\n<td>\n<p>Access restricted and controlled at all times.</p>\n<p>Medical surveillance of laboratory workers.</p>\n</td>\n<td>\n<p>Appropriate PPE must be worn, and respirators might be required.</p>\n<p>BSC for all activities.</p>\n</td>\n<td>\n<p>Hands-free sink and eyewash.</p>\n<p>Directional airflow from clean areas towards potentially contaminated areas.</p>\n<p>Entrance to the lab is through 2 self-closing and interlocked doors.</p>\n</td>\n</tr>\n<tr>\n<td><strong>BSL 4</strong></td>\n<td>\n<p>Change clothing before entering and shower upon exiting.</p>\n<p>Decontaminate all materials before exiting.</p>\n</td>\n<td>\n<p>BSC and full-body, air-supplied, positive pressure suit.</p>\n<p>Double-ended autoclave (through the wall).</p>\n</td>\n<td>\n<p>Laboratory in a separate building or isolated in a restricted zone.</p>\n<p>Dedicated supply and exhaust air, as well as vacuum lines and decontamination systems.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6842",
      "difficulty": "medium"
    },
    {
      "text": "An elderly patient was rushed to the casualty following bouts of severe breathlessness. He reported a history of fever and cough for the past 3 days. On examination, his SpO2 was 85% and RR was 32/min. CT scan is shown below. What is the gold standard investigation for his diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "CLIA"
        },
        {
          "id": 2,
          "text": "ELISA"
        },
        {
          "id": 3,
          "text": "RAT"
        },
        {
          "id": 4,
          "text": "RT-PCR"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\">The given clinical scenario, along with<span class=\"language en\" title=\"English\"><strong>&nbsp;</strong></span>CT showing bilateral multiple patchy consolidation and grid-like thickness of interlobular septa, is suggestive of <strong>COVID-19</strong>.&nbsp;The <strong>gold standard</strong> for its diagnosis is the identification of viral genome targets in the respiratory tract materials by <strong>reverse transcriptase&nbsp;polymerase chain reaction (RT-PCR)</strong>&nbsp;during the first week of symptoms.</p>\n<p><strong>RT-PCR</strong>&nbsp;involves the reverse transcription of the genetic material of the virus (RNA) to complementary DNA (cDNA), followed by amplification of some regions of the cDNA. Four regions of the SARS CoV2 genome are used as targets:</p>\n<ul>\n<li>RdRp gene (RNA-dependent RNA polymerase)&nbsp;</li>\n<li>Genes from structural proteins&nbsp;</li>\n<ul>\n<li>E (virus envelope)&nbsp;</li>\n<li>N (virus nucleocapsid),&nbsp;</li>\n</ul>\n<li>ORF1ab gene (open reading frame 1a and 1b)&nbsp;</li>\n</ul>\n<p><strong>CBNAAT </strong>(cartridge-based nucleic acid amplification test) uses small, chip-based, portable, battery-operated devices that detect target <strong>genetic material</strong> of SARS CoV2. Examples include <strong>TrueNat</strong> and <strong>Cepheid Xpert Xpress SARS CoV-2</strong></p>\n<p>Options A and B: <strong>Antibody testing-</strong>&nbsp;Antibodies of IgA, IgM, and IgG isotypes specific to different virus proteins are detected by enzyme-linked immunosorbent assay (ELISA) or chemiluminescence immunoassays (CLIA). CLIA is more sensitive compared to ELISA.</p>\n<p>Option C:&nbsp;<strong>Rapid antigen test (RAT)-</strong>&nbsp;Antigen-based assays are used as point-of-care tests for early detection of SARS-CoV-2. They are used at the field level for <strong>early detection</strong> of infection and quick <strong>containment</strong>. Most of such tests have relatively moderate sensitivity but high specificity. They are used for diagnosis along with RT-PCR.&nbsp;</p><p>ICMR has recently approved <strong>CoviSelf</strong> (nasal swab) for<strong> home testing </strong>of COVID-19 by <strong>RAT. </strong>It&nbsp;is advised only in symptomatic individuals and immediate contacts of laboratory confirmed positive cases. All individuals who test positive may be considered as true positives and <strong>no repeat testing</strong> is required.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1f445db4ed8a460a948006ca63a04b9a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3914",
      "difficulty": "easy"
    },
    {
      "text": "Choose the correct statement regarding testing of COVID-19:",
      "choices": [
        {
          "id": 1,
          "text": "All newborns must be tested."
        },
        {
          "id": 2,
          "text": "All pregnant women must be tested for COVID-19 in the first trimester."
        },
        {
          "id": 3,
          "text": "No individual can voluntarily subject themselves to COVID-19 test."
        },
        {
          "id": 4,
          "text": "A single positive RT-PCR test is considered confirmatory without repeat testing."
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A <strong>single RT-PCR/TrueNat/CBNAAT/RAT positive </strong>is considered<strong> confirmatory </strong>without repeat testing. If symptoms develop following a negative RAT, a repeat RAT or RT-PCR should be done.</p>\n<p><strong>Routine surveillance</strong> in <strong>containment zones</strong> and <strong>screening</strong> at points of entry for all <strong>symptomatic</strong> cases including:</p>\n<ul>\n<li>Healthcare and frontline workers</li>\n<li>Direct and high-risk contacts and individuals</li>\n</ul>\n<p><strong>Routine surveillance</strong> in <strong>non-containment</strong> areas&nbsp;for all <strong>symptomatic</strong> cases including:</p>\n<ul>\n<li>History of international travel in the last 14 days&nbsp;</li>\n<li>Contacts of a laboratory-confirmed case&nbsp;</li>\n<li>Healthcare and frontline workers involved in containment and mitigation activities&nbsp;</li>\n<li>Returnees and migrants within 7 days of illness&nbsp;</li>\n<li>All asymptomatic high-risk contacts&nbsp;</li>\n</ul>\n<p>In <strong>hospital</strong> settings&nbsp;for all <strong>symptomatic</strong> cases including:</p>\n<ul>\n<li>All patients of Severe Acute Respiratory Infection (SARI)</li>\n<li>Patients presenting in a healthcare setting&nbsp;</li>\n<li><strong>Neonates</strong> presenting with acute respiratory/sepsis-like illness</li>\n<li>Patients with atypical manifestations (stroke, encephalitis, hemoptysis, Guillain Barre Syndrome etc.) based on the doctor's discretion</li>\n<li>All <strong>pregnant women in/near labor</strong> hospitalized for delivery</li>\n<li>Asymptomatic high-risk patients who are hospitalized or seeking immediate hospitalization (eg. immune compromise, malignancy, transplant, chronic comorbidities, elderly &gt; 65 years)</li>\n</ul>\n<p><strong>Testing on-demand</strong> for all individuals:</p>\n<ul>\n<li>Traveling to countries/states mandating negative COVID-19 test at the point of entry</li>\n<li>Who <strong>wish to get themselves tested</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6827",
      "difficulty": "easy"
    },
    {
      "text": "A woman, whose husband has tested positive for COVID-19, comes to the clinic with a negative report on the rapid antigen test. She is currently asymptomatic. What will be the next step?",
      "choices": [
        {
          "id": 1,
          "text": "Retest with rapid antigen test after 5 days"
        },
        {
          "id": 2,
          "text": "Retest with RT-PCR after 5 days"
        },
        {
          "id": 3,
          "text": "Retest with RT-PCR immediately"
        },
        {
          "id": 4,
          "text": "Retest with RT-PCR if symptoms develop"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Asymptomatic </strong>individuals with a<strong> negative rapid antigen test</strong> (RAT) need to be <strong>retested only if they develop symptoms</strong> of COVID-19 such as cough, fever, and difficulty in breathing.</p>\n<p>Rapid antigen test, when positive, is reported as positive in both symptomatic and asymptomatic patients. When the test is negative, the patient is retested with another RAT or RT-PCR only if the patient is symptomatic.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6824",
      "difficulty": "medium"
    },
    {
      "text": "A man presents to the flu clinic with complaints of fever and sore throat for the past 4 days. COVID-19 is suspected and a paper-based test kit as shown below is used for testing. Identify the test.",
      "choices": [
        {
          "id": 1,
          "text": "TRUNAT"
        },
        {
          "id": 2,
          "text": "FELUDA"
        },
        {
          "id": 3,
          "text": "COVID Kavach ELISA"
        },
        {
          "id": 4,
          "text": "Q COVID-19 Ag  Test"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>paper-based Covid-19 test kit</strong> developed by CSIR and IGIB and approved by the Drugs Controller General of India (DCGI) is named <strong>FELUDA.</strong></p>\n<p><strong>FELUDA</strong> is an acronym for <strong>FNCAS9 Editor Linked Uniform Detection Assay.</strong>&nbsp;The name is inspired by a fictitious detective character in novels written by Satyajit Ray.</p>\n<p>FELUDA uses <strong>CRISPR-Cas9 technology</strong> (CRISPR = Clustered Regularly Interspaced Short Palindromic Repeats). The CRISPR technology uses a highly specific CAS9 protein to find and bind to the target Covid signature. This is then coupled with paper-strip chemistry to elicit a visual readout on a paper strip. It is a very affordable, sensitive (96%), and specific (98%) strip test which can detect viral genetic material within <strong>45 minutes.</strong></p><p>FELUDA test has been commercially launched in India as '<strong>TataMD CHECK CRISPR Test</strong>' by TATA Medical and Diagnostics Ltd.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7342e17f911f48b3a9ccfe6a58ce4bba.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6840",
      "difficulty": "medium"
    },
    {
      "text": "What is the name of the COVID-19 IgG antibody detection ELISA test kit developed by ICMR and NIV?",
      "choices": [
        {
          "id": 1,
          "text": "COVID Nischay ELISA"
        },
        {
          "id": 2,
          "text": "COVID Aarogya ELISA"
        },
        {
          "id": 3,
          "text": "COVID Kavach ELISA"
        },
        {
          "id": 4,
          "text": "COVID Sankalp ELISA"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>COVID Kavach ELISA</strong> is an<strong> indigenous ELISA test kit</strong> for COVID-19 antibody detection developed by <strong>ICMR Delhi</strong> and <strong>NIV Pune.</strong></p>\n<p>It is reported to have a 98.7% sensitivity and 100% specificity and testing is possible even at the district level. As the ELISA kit has an <strong>inactivated virus</strong>, only minimal biosafety and biosecurity requirements as compared to the real-time RT-PCR test.&nbsp;</p>\n<p>IgG antibodies usually start appearing after two weeks of the onset of infection. Therefore, the IgG test is not useful for detecting acute infection. <strong>IgG based antibody tests</strong> are used in <strong>sero-surveillance</strong> of the population.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6841",
      "difficulty": "medium"
    },
    {
      "text": "What is least likely to be seen in a patient suspected of COVID-19?",
      "choices": [
        {
          "id": 1,
          "text": "Elevated transaminases"
        },
        {
          "id": 2,
          "text": "Elevated fibrinogen"
        },
        {
          "id": 3,
          "text": "Lymphocytosis"
        },
        {
          "id": 4,
          "text": "Prolonged prothrombin time"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Lymphocytosis is least likely to be seen in a patient with <strong>COVID-19</strong>. On the contrary, <strong>lymphopenia</strong> is likely to be seen.&nbsp;</p>\n<p><strong>Common laboratory abnormalities</strong> seen in COVID-19 are:</p>\n<ul>\n<li>Lymphopenia</li>\n<li>Mild thrombocytopenia</li>\n<li>Elevated aminotransaminase levels</li>\n<li>Elevated lactate dehydrogenase levels</li>\n<li>Elevated inflammatory markers - eg, ferritin, C-reactive protein, and erythrocyte sedimentation rate</li>\n<li>Markers of a hypercoagulable state -&nbsp;high fibrinogen, high D-dimer levels, increased fibrin degradation products, prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT)&nbsp;</li>\n</ul>\n<p>The degree of these abnormalities tends to correlate with disease severity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3917",
      "difficulty": "medium"
    },
    {
      "text": "What is the most commonly seen pattern in chest CT of patients affected with COVID-19?",
      "choices": [
        {
          "id": 1,
          "text": "Interlobular septal thickenings"
        },
        {
          "id": 2,
          "text": "Air bronchograms"
        },
        {
          "id": 3,
          "text": "Ground glass opacity"
        },
        {
          "id": 4,
          "text": "Crazy paving pattern"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Ground glass opacity (GGO)</strong> is the <strong>most commonly seen pattern</strong> in chest CT of patients with <strong>COVID-19</strong>.&nbsp;</p>\n<p>Some of the typical features seen in the CT scans of COVID-19 patients include:</p>\n<ul>\n<li>Ground glass opacities</li>\n<li>Consolidation</li>\n<li>Air bronchograms</li>\n<li>Interlobular septal thickenings</li>\n<li>Visible intralobular lines (crazy-paving pattern)</li>\n<li>Reversed halo sign&nbsp;</li>\n</ul><p>The image below shows an axial CT scan with multiple patchy areas of pure <strong>ground-glass opacities</strong>.&nbsp;GGO are hazy areas with slightly increased density in the lungs without obscuration of underlying bronchial and vascular margins.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/830631c7af074a2fba6e47e93865feacx986x608.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image given below shows a CT scan with&nbsp;bilateral GGO in the lower lobe and an&nbsp;<strong>air bronchogram </strong>(arrow) in the left subpleural area. Air bronchograms appear like air-filled bronchi within a highly attenuated parenchymal background. These are dilated bronchi filled with <strong>mucus plugs</strong> and do not truly contain air.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d86285ee7a5b44ddae4aa941f7284814x1280x1010.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image given below shows a CT scan with&nbsp;<strong>multiple consolidation areas </strong>and<strong>&nbsp;interlobular septal thickening </strong>(arrows) in both lungs. The pulmonary interstitial structures such as interlobular septa and intralobular lines can thicken and&nbsp;manifest as small linear opacities.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2170fe46cbe6435a99b97521af63dca5x1280x1010.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image given below shows a CT scan with&nbsp;<strong>crazy-paving pattern</strong> (circled area). It is defined as the presence of GGOs with superimposed interlobular septal thickening giving the appearance of irregular paving stones.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6bf628c88803466fba7b3f0c0f943153x1280x940.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image given below shows a CT scan with multiple lesions with reversed halo sign (arrows).&nbsp;The <strong>reversed halo sign</strong>&nbsp;or <strong>atoll sign</strong>&nbsp;is the presence of a ring-like area of consolidation with a superimposed rounded GGO.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b7998c2151bd4abd94bf1c0f4d629fb8x1280x397.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3927",
      "difficulty": "easy"
    },
    {
      "text": "Increased concentrations of all of the following are poor prognostic markers in a COVID-19 patient except:",
      "choices": [
        {
          "id": 1,
          "text": "Glycosylated ferritin"
        },
        {
          "id": 2,
          "text": "C-reactive protein"
        },
        {
          "id": 3,
          "text": "N-terminal pro-BNP"
        },
        {
          "id": 4,
          "text": "Procalcitonin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Glycosylated ferritin</strong> is <strong>decreased</strong> in severe COVID-19 illness and hence, it is not a&nbsp;poor prognostic marker.</p>\n<p>Interestingly, in contrast to <strong>ferritin</strong> which is actually <strong>elevated</strong> in individuals with COVID 19, the glycosylated ferritin is decreased. It is a potentially <strong>sensitive biomarker</strong> that can better discriminate severe COVID than ferritin alone.</p>\n<p>Increased levels of the following laboratory markers is associated with poorer outcomes:</p>\n<ul>\n<li>D-dimer</li>\n<li>C-reactive protein</li>\n<li>Lactate dehydrogenase</li>\n<li>Cardiac troponin</li>\n<li>Ferritin</li>\n<li>Creatinine phosphokinase</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6835",
      "difficulty": "hard"
    },
    {
      "text": "Which inflammatory marker is of prognostic significance in COVID-19 patients?",
      "choices": [
        {
          "id": 1,
          "text": "IL-6"
        },
        {
          "id": 2,
          "text": "ESR"
        },
        {
          "id": 3,
          "text": "NLR"
        },
        {
          "id": 4,
          "text": "PCT"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Elevated pro-inflammatory cytokines like interleukin-6 (<strong>IL-6</strong>) are associated with critical and fatal COVID-19. It is specifically useful in <strong>predicting</strong> <strong>prognosis </strong>of such patients.</p>\n<p>Increased levels of the following laboratory markers are associated with poorer outcomes:</p>\n<ul>\n<li>D-dimer</li>\n<li>C-reactive protein</li>\n<li>Lactate dehydrogenase</li>\n<li>Cardiac troponin</li>\n<li>Ferritin</li>\n<li>Creatinine phosphokinase</li>\n</ul>\n<p>Options B, C and D: Inflammatory markers associated with increased severity of COVID-19 are:</p>\n<ul>\n<li><strong><strong>PCT </strong></strong>(procalcitonin test)</li>\n<li><strong>ESR</strong></li>\n<li>WBC</li>\n<li>LMR (lymphocyte/mean platelet volume ratio)</li>\n<li>HsCRP (high-sensitivity C-reactive protein)</li>\n<li><strong>NLR</strong> (neutrophil to lymphocyte ratio)&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7459",
      "difficulty": "medium"
    }
  ]
}